Reasons We Treat COVID-19 Patients With Anti-Malaria Drugs – NCDC DG

The Director-General of the National Center for Disease Control (NCDC), Chikwe Iheakweazu on Friday clarified why anti-malaria drugs are being administered to coronavirus COVID-19 patients.

The NCDC DG also explained the differences between COVID-19 and malaria.

This follows recent remarks by some prominent survivors, who spoke about the drugs administered to them during their treatment.

One of the survivors, the owner of DAAR Communications Raymond Dokpesi had  claimed that all the drugs administered on him were anti-malaria medication.

But speaking at the daily briefing of the Presidential Taskforce on COVID-19, the NCDC boss said: ”I think we all know COVID-19 is a respiratory illness caused by a virus. Malaria is caused by a parasite. They are completely different diseases.

“However, many diseases present exactly the same way in the beginning. Yellow fever presents the same way with fever at the beginning, Lassa fever the same way with malaria,” he said.

He further said that: “So, the initial presentation of a febrile illness is similar across diseases. There is no specific treatment for COVID-19. What clinicians do is to manage your symptoms so that your body recovers as quickly as possible.

READ ALSO:China Admits To Destroying Early Coronavirus Samples

“You can have Malaria and COVID-19. That you have COVID-19 doesn’t prevent you from having Malaria and if you are in a hospital for one month, you could definitely be co-infected by both of them.

“So there are many reasons why people receive similar treatments but they are two completely different diseases with different parthenogenesis.” Chikwe Iheakweazu said.